Uncategorized

Pfizer to halt development of closely watched weight-loss drug – Financial Times

Posted on Author Tim Hodges Comments Off on Pfizer to halt development of closely watched weight-loss drug – Financial Times
  1. Pfizer to halt development of closely watched weight-loss drug  Financial Times
  2. Pfizer scraps daily weight loss pill after liver injury in one patient  CNBC
  3. Pfizer discontinues GLP-1 pill trial, stock trades flat  Yahoo Finance
  4. Pfizer ends development of potential pill obesity treatment  AP News
  5. Pfizer Abandons Obesity Pill After Liver Injury in Setback  Bloomberg.com